Characterization of the CD49f+/CD44+/CD24- single-cell derived stem cell population in basal-like DCIS cells

Oncotarget

Volumn 7, Issue 30, 2016, Pages 47511-47525

  Duru, Nadire ^a   Gernapudi, Ramkishore ^a   Lo, Pang Kuo ^a   Yao, Yuan ^a   Wolfson, Benjamin ^a   Zhang, Yongshu ^a   Zhou, Qun ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer stem cells; DCIS; Non coding RNAs; Single cell cloning; Tumor heterogeneity

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 1; ALPHA6 INTEGRIN; CD24 ANTIGEN; HERMES ANTIGEN; KI 67 ANTIGEN; LONG UNTRANSLATED RNA; MICRORNA 10B; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; OCTAMER TRANSCRIPTION FACTOR 4; REGULATOR OF REPROGRAMMING; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; CD24 PROTEIN, HUMAN; CD44 PROTEIN, HUMAN; HYALURONIC ACID BINDING PROTEIN; POU5F1 PROTEIN, HUMAN; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GROWTH; CANCER RECURRENCE; CANCER STEM CELL; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL POPULATION; CELL SELF-RENEWAL; CLONOGENESIS; CONTROLLED STUDY; DNA METHYLATION; DNA REPAIR; ENZYME ACTIVITY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE IN SITU HYBRIDIZATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SIGNAL TRANSDUCTION; STEM CELL; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; BREAST TUMOR; CELL MOTION; INTRADUCTAL CARCINOMA; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CD24 ANTIGEN; CELL LINE, TUMOR; CELL MOVEMENT; DNA METHYLATION; FEMALE; HUMANS; HYALURONAN RECEPTORS; INTEGRIN ALPHA6; MICE; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; SOXB1 TRANSCRIPTION FACTORS;

EID: 84982843407     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.10203     Document Type: Article

References (28)

1. Espina V, Mariani BD, Gallagher RI, Tran K, Banks S, Wiedemann J Huryk H, Mueller C, Adamo L, Deng J, Petricoin EF, Pastore L, Zaman S, et al. Malignant Precursor Cells Pre-Exist in Human Breast DCIS and Require Autophagy for Survival. PLoS ONE. 2010; 5:e10240. doi: 10.1371/journal.pone.0010240.
2. Leonard GD, Swain SM. Ductal Carcinoma In Situ, Complexities and Challenges. J Natl Cancer. Inst 2004; 96:906-920.
3. Fowble B, Hanlon A, Fein D, Hoffman J, Sigurdson E, Patchefsky A, Kessler H. Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS). Int J Radiat Oncol Biol Phys. 1997; 38:949-957.
4. Li Q, Yao Y, Eades G, Liu Z, Zhang Y, Zhou Q. Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer. Oncogene. 2013; 33:2589-2600. doi: 10.1038/onc.2013.226.
5. Li Q, Eades G, Yao Y, Zhang Y, Zhou Q. Characterization of a stem-like subpopulation in basal-like ductal carcinoma in situ (DCIS) lesions. J Biol Chem. 2014; 289:1303-1312. doi: 10.1074/jbc.M113.502278.
6. Shackleton M, Quintana E, Fearon ER, Morrison SJ. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell. 2009; 138:822-829. doi: 10.1016/j. cell.2009.08.017.
7. Diaz-Cano SJ. Tumor Heterogeneity: Mechanisms and Bases for a Reliable Application of Molecular Marker Design. Int J Mol Sci. 2012; 13:1951-2011. doi: 10.3390/ijms13021951.
8. Meyer M, Reimand J, Lan X, Head R, Zhu X, Kushida M, Bayani J, Pressey JC, Lionel AC, Clarke ID, Cusimano M, Squire JA, Scherer SW, et al. Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity. Proc Natl Acad Sci U S A. 2015; 112:851-856. doi: 10.1073/pnas.1320611111.
9. Lawson DA, Bhakta NR, Kessenbrock K, Prummel KD, Yu Y, Takai K, Zhou A, Eyob H, Balakrishnan S, Wang CY, Yaswen P, Goga A, Werb Z. Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells. Nature. 2015; 526:131-135. doi: 10.1038/nature15260.
10. Miller FR, Santner SJ, Tait L, Dawson PJ. MCF10DCIS. com xenograft model of human comedo ductal carcinoma in situ. J Natl Cancer Inst. 2000; 92:1185-1186.
11. Ghebeh H, Sleiman GM, Manogaran PS, Al-Mazrou A, Barhoush E, Al-Mohanna FH, Tulbah A, Al-Faqeeh K, Adra CN. Profiling of normal and malignant breast tissue show CD44high/CD24low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers. BMC Cancer. 2013; 13:289. doi: 10.1186/1471-2407-13-289.
12. Ehrlich, M. DNA hypomethylation in cancer cells. Epigenomics. 2009; 1:239-259. doi: 10.2217/epi.09.33.
13. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007; 1:555-567. doi: 10.1016/j.stem.2007.08.014.
14. Cheung KJ, Gabrielson E, Werb Z, Ewald AJ. Collective Invasion in Breast Cancer Requires a Conserved Basal Epithelial Program. Cell. 2013; 155:1639-1651. doi: 10.1016/j.cell.2013.11.029.
15. Hashimoto S, Onodera Y, Hashimoto A, Tanaka M, Hamaguchi M, Yamada A, Sabe H. Requirement for Arf6 in breast cancer invasive activities. Proc Natl Acad Sci U S A. 2004; 101:6647-6652.
16. Eades G, Wolfson B, Zhang Y, Li Q, Yao Y, Zhou Q. lincRNA-RoR and miR-145 regulate invasion in triplenegative breast cancer via targeting ARF6. Mol Cancer Res. 2015; 13:330-338. doi: 10.1158/1541-7786.MCR-14-0251.
17. Liu A, Yu X, Liu S. Pluripotency transcription factors and cancer stem cells: small genes make a big difference. Chin J Cancer. 2013; 32:483-487. doi: 10.5732/cjc.012.10282.
18. Tang B, Raviv A, Esposito D, Flanders KC, Daniel C, Nghiem BT, Garfield S, Lim L, Mannan P, Robles AI, Smith WI Jr, Zimmerberg J, Ravin R, et al. A flexible reporter system for direct observation and isolation of cancer stem cells. Stem Cell Reports. 2015; 4:155-169. doi: 10.1016/j.stemcr.2014.11.002.
19. Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, Park IH, Garber M, Curran M, Onder T, Agarwal S, Manos PD, Datta S, Lander ES et al. Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet. 2010; 42:1113-1117. doi: 10.1038/ng.710.
20. Wang Y, Xu Z, Jiang J, Xu C, Kang J, Xiao L, Wu M, Xiong J, Guo X, Liu H. Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev Cell. 2013; 25:69-80. doi: 10.1016/j.devcel.2013.03.002.
21. Eades G, Zhang Y, Li Q, Xia J, Yao Y, Zhou Q. Long noncoding RNAs in stem cells and cancer. World J Clin Oncol. 2014; 5:134-141. doi: 10.5306/wjco.v5.i2.134.
22. Zhang Y, Xia J, Li Q, Yao Y, Eades G, Gernapudi R, Duru N, Kensler TW, Zhou Q. NRF2/long noncoding RNA ROR signaling regulates mammary stem cell expansion and protects against estrogen genotoxicity. J Biol Chem. 2014; 289:31310-31318. doi: 10.1074/jbc.M114.604868.
23. Volinia S, Galasso M, Sana ME, Wise TF, Palatini J, Huebner K, Croce CM. Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. Proc Natl Acad Sci U S A. 2012; 109: 3024-3029. doi: 10.1073/pnas.1200010109.
24. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007; 449 :682-688.
25. Chou J, Lin JH, Brenot A, Kim JW, Provot S, Werb Z. GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression. Nat Cell Biol. 2013; 15:201-213. doi: 10.1038/ncb2672.
26. Park SM, Gaur AB, Lengyel E, Peter ME. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008; 22:894-907. doi: 10.1101/gad.1640608.
27. Eades G, Yao Y, Yang M, Zhang Y, Chumsri S, Zhou Q. miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells. J Biol Chem. 2011; 286: 25992-26002. doi: 10.1074/jbc.M111.229401.
28. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson EG, Teruya-Feldstein J, Bell GW, Weinberg RA. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol. 2010; 28:341-347. doi: 10.1038/nbt.1618.